UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6026
iShares MSCI China Small-Cap ETF
ECNS
$58.9M
| $646K | ﹤0.01% |
22,953
+1,251
| +6% | +$40.2K |
2014 Q4
46 quarters
|
|
6027
PUT
Iris Energy
IREN
$8.76B
| $646K | ﹤0.01% |
+14,118
| New | +$734K |
2026 Q2
0 quarters
|
|
6028
Stevanato
STVN
$3.71B
| $646K | ﹤0.01% |
35,727
-48,122
| -57% | -$813K |
2023 Q3
11 quarters
|
|
6029
2x Solana ETF
SOLT
$131M
| $644K | ﹤0.01% |
19,945
| – | – |
2025 Q4
2 quarters
|
|
6030
Aldeyra Therapeutics
ALDX
$38.2M
| $643K | ﹤0.01% |
301,940
-235,629
| -44% | -$405K |
2017 Q1
37 quarters
|
|
|
ILLR
6031
DELISTED
TRILLER GROUP INC
ILLR
| $640K | ﹤0.01% |
+236,311
| New | +$565K |
2026 Q2
0 quarters
|
|
6032
CALL
Veeva Systems
VEEV
$49.2B
| $639K | ﹤0.01% |
3,600
-900
| -20% | -$148K |
2025 Q2
4 quarters
|
|
6033
UNIFI
UFI
$108M
| $637K | ﹤0.01% |
134,172
+26,426
| +25% | +$105K |
2014 Q4
46 quarters
|
|
6034
Astec Industries
ASTE
$822M
| $637K | ﹤0.01% |
10,412
-96,810
| -90% | -$5.34M |
2014 Q4
46 quarters
|
|
6035
Agora
API
$355M
| $636K | ﹤0.01% |
159,464
-811,410
| -84% | -$3.26M |
2020 Q3
23 quarters
|
|
6036
Nayax
NYAX
$1.78B
| $636K | ﹤0.01% |
9,707
+2,459
| +34% | +$163K |
2022 Q3
15 quarters
|
|
6037
LENZ Therapeutics
LENZ
$110M
| $635K | ﹤0.01% |
111,825
-45,164
| -29% | -$364K |
2021 Q3
19 quarters
|
|
6038
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$812M
| $629K | ﹤0.01% |
129,856
-3,635
| -3% | -$18.9K |
2014 Q4
46 quarters
|
|
6039
Ramaco Resources Class B
METCB
$248M
| $628K | ﹤0.01% |
75,297
+972
| +1% | +$9.8K |
2023 Q2
12 quarters
|
|
6040
Nuveen Real Asset Income & Growth Fund
JRI
$421M
| $628K | ﹤0.01% |
48,423
+1,534
| +3% | +$19.7K |
2014 Q4
46 quarters
|
|
6041
Milestone Pharmaceuticals
MIST
$95M
| $624K | ﹤0.01% |
465,403
-29,505
| -6% | -$47.2K |
2024 Q4
6 quarters
|
|
6042
ProShares Ultra Gold
UGL
$678M
| $622K | ﹤0.01% |
14,186
+1,545
| +12% | +$87.2K |
2025 Q4
2 quarters
|
|
6043
PUT
Sherwin-Williams
SHW
$83.1B
| $620K | ﹤0.01% |
1,800
-2,500
| -58% | -$799K |
2024 Q1
9 quarters
|
|
6044
CALL
POET Technologies
POET
$877M
| $617K | ﹤0.01% |
+60,000
| New | +$653K |
2026 Q2
0 quarters
|
|
6045
CALL
Kroger
KR
$40B
| $616K | ﹤0.01% |
11,100
-40,000
| -78% | -$2.61M |
2025 Q1
5 quarters
|
|
6046
Jakks Pacific
JAKK
$388M
| $615K | ﹤0.01% |
26,422
-5,465
| -17% | -$121K |
2021 Q2
20 quarters
|
|
6047
Eaton Vance Senior Income Trust
EVF
$87.9M
| $614K | ﹤0.01% |
123,215
+537
| +0.4% | +$2.67K |
2014 Q4
46 quarters
|
|
6048
EDAP TMS S.A.
FOCL
$157M
| $613K | ﹤0.01% |
118,395
-51,235
| -30% | -$209K |
2023 Q4
10 quarters
|
|
6049
Rocky Brands
RCKY
$387M
| $613K | ﹤0.01% |
14,868
+12,348
| +490% | +$483K |
2015 Q2
44 quarters
|
|
6050
Electromed
ELMD
$225M
| $613K | ﹤0.01% |
14,487
+5,210
| +56% | +$167K |
2024 Q3
7 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.